Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

Residual DNA Testing is vital in detecting trace DNA post-biological processes, crucial for safety across biotechnology, pharmaceuticals, and forensics. It ensures biopharmaceuticals like vaccines are ...

The audacity of the Cuban regime seems to know no bounds: as citizens endure power outages lasting up to 20 hours daily and ...

Annually, the lab processes and tests over 1,500 fish samples. The lab uses a wide variety of specialized techniques such as necropsy, bacteriology, parasitology, virus isolation and polymerase chain ...

The global sales of Zika virus testing is estimated to be worth USD 244.7 million in 2025 and anticipated to reach a value of ...

Breakthrough Innovations Drive Expansion of the Global Infectious Disease Diagnostics MarketThe Global Infectious Disease ...

Anbio Biotechnology is a medical device firm develops in-vitro diagnostics, with stock volatility & thin public float. Read ...

Co-Diagnostics (CODX) announced the development of a proprietary sample preparation instrument designed to streamline and simplify the workflow ...

“The Nu.Q® Vet Cancer Test is intended for use during regular preventive check-ups of older dogs (seven years and older) or for younger dogs of high-risk breeds and we were delighted to offer the ...

Three-year-old boy in Kerala diagnosed with amoebic infection, raising concerns of rare but fatal brain infection.

In the last 30 days, the USDA has confirmed highly pathogenic avian influenza H5N1, in 47 cases in poultry in 13 states.

Oxford BioDynamics has welcomed a new report that calls for the introduction of targeted prostate cancer screening in the UK.